New study supports benefits of INI's Cinnulin

Integrity Nutraceuticals International says that a water-soluble cinnamon extract, similar to the one it markets as Cinnulin PF, reduces fasting blood sugar levels in patients with type 2 diabetes. The data, published in a recent issue of the European Journal of Clinical Investigation, demonstrates that supplementation with a water-soluble cinnamon extract may play an important role in managing blood sugar levels and improving insulin function.

The placebo-controlled, double-blind evaluation was designed to determine the effect of the extract on glycemic control and cardiovascular risk factors in a total of 79 patients with type 2 diabetes not on insulin therapy but treated with oral medication or diet therapy.

The tested agent contained 112mg of water-soluble extract, equivalent to 1g of cinnamon powder. This group experienced a significant reduction in fasting plasma glucose levels (10.3%) versus the placebo arm (3.4%), although changes in HbA1c and lipid profiles were not statistically significant.